Isoform Selective Phosphoinositide 3-Kinase amp;#947; and amp;#948; Inhibitors and Their Therapeutic Potential

E-ISSN： 2212-2710|2|1|1-10

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.2, Iss.1, 2008-01, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphoinositide 3-Kinase Gamma (PI3K&ggr;) Inhibitors for the Treatment of Inflammation and Autoimmune Disease

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 1, 2010-01 ,pp. : 1-15

Bentham Science Publishers

Access to resources Recommend Favorite

Regeneration of Pancreatic &bgr;-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 135-143

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 89-98

Bentham Science Publishers

Access to resources Recommend Favorite

The Two Faces of Protein Palmitoylation in Islet &bgr;-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 3, 2013-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 173-178

Bentham Science Publishers

Access to resources Recommend Favorite